200 related articles for article (PubMed ID: 17146446)
1. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer.
Bloch M; Ousingsawat J; Simon R; Schraml P; Gasser TC; Mihatsch MJ; Kunzelmann K; Bubendorf L
Oncogene; 2007 Apr; 26(17):2525-34. PubMed ID: 17146446
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
Ruiz C; Holz DR; Oeggerli M; Schneider S; Gonzales IM; Kiefer JM; Zellweger T; Bachmann A; Koivisto PA; Helin HJ; Mousses S; Barrett MT; Azorsa DO; Bubendorf L
J Pathol; 2011 Mar; 223(4):543-52. PubMed ID: 21294127
[TBL] [Abstract][Full Text] [Related]
3. Role of KCNMA1 in breast cancer.
Oeggerli M; Tian Y; Ruiz C; Wijker B; Sauter G; Obermann E; Güth U; Zlobec I; Sausbier M; Kunzelmann K; Bubendorf L
PLoS One; 2012; 7(8):e41664. PubMed ID: 22899999
[TBL] [Abstract][Full Text] [Related]
4. Amplification of urokinase gene in prostate cancer.
Helenius MA; Saramäki OR; Linja MJ; Tammela TL; Visakorpi T
Cancer Res; 2001 Jul; 61(14):5340-4. PubMed ID: 11454671
[TBL] [Abstract][Full Text] [Related]
5. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.
Lallet-Daher H; Roudbaraki M; Bavencoffe A; Mariot P; Gackière F; Bidaux G; Urbain R; Gosset P; Delcourt P; Fleurisse L; Slomianny C; Dewailly E; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
Oncogene; 2009 Apr; 28(15):1792-806. PubMed ID: 19270724
[TBL] [Abstract][Full Text] [Related]
6. MCM7 amplification and overexpression are associated with prostate cancer progression.
Ren B; Yu G; Tseng GC; Cieply K; Gavel T; Nelson J; Michalopoulos G; Yu YP; Luo JH
Oncogene; 2006 Feb; 25(7):1090-8. PubMed ID: 16247466
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.
Haapala K; Kuukasjärvi T; Hyytinen E; Rantala I; Helin HJ; Koivisto PA
Hum Pathol; 2007 Mar; 38(3):474-8. PubMed ID: 17217995
[TBL] [Abstract][Full Text] [Related]
8. Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
Jung V; Kindich R; Kamradt J; Jung M; Müller M; Schulz WA; Engers R; Unteregger G; Stöckle M; Zimmermann R; Wullich B
Mol Cancer Res; 2006 Mar; 4(3):169-76. PubMed ID: 16547154
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
[TBL] [Abstract][Full Text] [Related]
10. Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.
Murphy AJ; Hughes CA; Barrett C; Magee H; Loftus B; O'Leary JJ; Sheils O
Cancer Res; 2007 Mar; 67(6):2893-8. PubMed ID: 17363613
[TBL] [Abstract][Full Text] [Related]
11. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
Bubendorf L
Verh Dtsch Ges Pathol; 2004; 88():158-64. PubMed ID: 16892547
[TBL] [Abstract][Full Text] [Related]
12. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the KCNMA1 potassium channel alpha subunit as risk factor for severe essential hypertension and myocardial infarction.
Tomás M; Vázquez E; Fernández-Fernández JM; Subirana I; Plata C; Heras M; Vila J; Marrugat J; Valverde MA; Sentí M
J Hypertens; 2008 Nov; 26(11):2147-53. PubMed ID: 18854754
[TBL] [Abstract][Full Text] [Related]
14. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
Mäki HE; Saramäki OR; Shatkina L; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Cato AC; Visakorpi T
J Pathol; 2007 Aug; 212(4):395-401. PubMed ID: 17503439
[TBL] [Abstract][Full Text] [Related]
15. Endocytic trafficking signals in KCNMB2 regulate surface expression of a large conductance voltage and Ca(2+)-activated K+ channel.
Zarei MM; Song M; Wilson RJ; Cox N; Colom LV; Knaus HG; Stefani E; Toro L
Neuroscience; 2007 Jun; 147(1):80-9. PubMed ID: 17521822
[TBL] [Abstract][Full Text] [Related]
16. Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis.
Sandle GI; Perry MD; Mathialahan T; Linley JE; Robinson P; Hunter M; MacLennan KA
J Pathol; 2007 May; 212(1):66-73. PubMed ID: 17405186
[TBL] [Abstract][Full Text] [Related]
17. TREK-1 is a novel molecular target in prostate cancer.
Voloshyna I; Besana A; Castillo M; Matos T; Weinstein IB; Mansukhani M; Robinson RB; Cordon-Cardo C; Feinmark SJ
Cancer Res; 2008 Feb; 68(4):1197-203. PubMed ID: 18281496
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
19. Cloning of potassium channel splice variants from tissues and cells.
Chen L; Shipston MJ
Methods Mol Biol; 2008; 491():35-60. PubMed ID: 18998082
[TBL] [Abstract][Full Text] [Related]
20. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
